These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulatory compliance for point-of-care testing. A perspective from the United States (Circa 2000). Lee-Lewandrowski E, Lewandrowski K. Clin Lab Med; 2001 Jun; 21(2):241-53, vii. PubMed ID: 11396081 [Abstract] [Full Text] [Related]
23. Drugs and chronic alcohol abuse in drivers. Appenzeller BM, Schneider S, Yegles M, Maul A, Wennig R. Forensic Sci Int; 2005 Dec 20; 155(2-3):83-90. PubMed ID: 16226145 [Abstract] [Full Text] [Related]
26. The role of urine toxicology in chronic opioid analgesic therapy. Compton P. Pain Manag Nurs; 2007 Dec 20; 8(4):166-72. PubMed ID: 18036504 [Abstract] [Full Text] [Related]
27. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Boumba VA, Ziavrou KS, Vougiouklakis T. Int J Toxicol; 2006 Dec 20; 25(3):143-63. PubMed ID: 16717031 [Abstract] [Full Text] [Related]
33. Point-of-care testing. Cost issues and impact on hospital operations. Foster K, Despotis G, Scott MG. Clin Lab Med; 2001 Jun 20; 21(2):269-84. PubMed ID: 11396083 [Abstract] [Full Text] [Related]
34. Selected topics in point-of-care testing. Urinalysis, pregnancy testing, microbiology, fecal occult blood, and other tests. Lee-Lewandrowski E, Lewandrowski K. Clin Lab Med; 2001 Jun 20; 21(2):389-404. PubMed ID: 11396091 [Abstract] [Full Text] [Related]
35. State of the art in hair analysis for detection of drug and alcohol abuse. Pragst F, Balikova MA. Clin Chim Acta; 2006 Aug 20; 370(1-2):17-49. PubMed ID: 16624267 [Abstract] [Full Text] [Related]
40. Are clinical impressions of adolescent substance use accurate? Wilson CR, Sherritt L, Gates E, Knight JR. Pediatrics; 2004 Nov 20; 114(5):e536-40. PubMed ID: 15520086 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]